What's in Dark Canyon Laboratories, LLC's pipeline?

Dark Canyon Laboratories, LLC has 1 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Dark Canyon Laboratories, LLC's portfolio?

Top competitors by shared drug class: Criterium, Inc., Mirati Therapeutics Inc., Revolution Medicines, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/dark-canyon-laboratories-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Dark Canyon Laboratories, LLC — Portfolio Competitive Intelligence Brief

Dark Canyon Laboratories, LLC pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Criterium, Inc. · 1 shared drug class
Mirati Therapeutics Inc. · 1 shared drug class
Revolution Medicines, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Dark Canyon Laboratories, LLC:

Cite this brief

Drug Landscape (2026). Dark Canyon Laboratories, LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/dark-canyon-laboratories-llc. Accessed 2026-05-16.